Sandra R. Wolman

6.0k total citations · 1 hit paper
103 papers, 4.8k citations indexed

About

Sandra R. Wolman is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Sandra R. Wolman has authored 103 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Cancer Research, 34 papers in Molecular Biology and 28 papers in Oncology. Recurrent topics in Sandra R. Wolman's work include Cancer Genomics and Diagnostics (21 papers), Genomic variations and chromosomal abnormalities (15 papers) and Cancer-related Molecular Pathways (11 papers). Sandra R. Wolman is often cited by papers focused on Cancer Genomics and Diagnostics (21 papers), Genomic variations and chromosomal abnormalities (15 papers) and Cancer-related Molecular Pathways (11 papers). Sandra R. Wolman collaborates with scholars based in United States, United Kingdom and Netherlands. Sandra R. Wolman's co-authors include Arleen D. Auerbach, Herbert D. Soule, Terry Maloney, Robert J. Pauley, S.C. Brooks, Charles M. McGrath, José Russo, Richard F. Jones, William Peterson and James E. Talmadge and has published in prestigious journals such as Nature, Science and Blood.

In The Last Decade

Sandra R. Wolman

102 papers receiving 4.6k citations

Hit Papers

Isolation and characterization of a spontaneously immorta... 1990 2026 2002 2014 1990 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra R. Wolman United States 32 2.5k 1.6k 1.5k 811 602 103 4.8k
Rufus S. Day United States 32 4.0k 1.6× 1.6k 1.0× 2.2k 1.5× 550 0.7× 440 0.7× 72 5.5k
Masaaki Terada Japan 45 3.8k 1.5× 986 0.6× 1.6k 1.1× 824 1.0× 477 0.8× 141 5.9k
Susanne M. Gollin United States 48 4.4k 1.8× 1.6k 1.0× 2.0k 1.4× 1.3k 1.6× 580 1.0× 141 7.2k
David Wynford‐Thomas United Kingdom 46 3.6k 1.4× 700 0.4× 2.6k 1.7× 825 1.0× 681 1.1× 158 7.0k
Kotoku Kurachi United States 48 4.4k 1.7× 1.2k 0.8× 1.1k 0.7× 1.3k 1.6× 580 1.0× 114 8.6k
L. A. Liotta United States 21 3.0k 1.2× 1.8k 1.1× 1.7k 1.1× 264 0.3× 534 0.9× 39 4.9k
Jean Bénard France 38 2.6k 1.0× 973 0.6× 1.8k 1.2× 357 0.4× 364 0.6× 150 4.5k
Johng S. Rhim United States 37 3.2k 1.3× 1.2k 0.8× 2.1k 1.4× 884 1.1× 449 0.7× 149 6.1k
Masayoshi Namba Japan 35 2.8k 1.1× 533 0.3× 1.1k 0.8× 594 0.7× 422 0.7× 186 4.8k
Catherine A. Reznikoff United States 28 2.2k 0.9× 925 0.6× 977 0.7× 549 0.7× 244 0.4× 70 4.1k

Countries citing papers authored by Sandra R. Wolman

Since Specialization
Citations

This map shows the geographic impact of Sandra R. Wolman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra R. Wolman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra R. Wolman more than expected).

Fields of papers citing papers by Sandra R. Wolman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra R. Wolman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra R. Wolman. The network helps show where Sandra R. Wolman may publish in the future.

Co-authorship network of co-authors of Sandra R. Wolman

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra R. Wolman. A scholar is included among the top collaborators of Sandra R. Wolman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra R. Wolman. Sandra R. Wolman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Worsham, Maria J., Usha Raju, Mei Lü, et al.. (2008). Risk factors for breast cancer from benign breast disease in a diverse population. Breast Cancer Research and Treatment. 118(1). 1–7. 42 indexed citations
2.
Raju, Usha, et al.. (2007). Risk factors for breast cancer from benign breast disease in a diverse population. Cancer Epidemiology and Prevention Biomarkers. 16. 1 indexed citations
3.
Wolman, Sandra R., Bryan Goldman, Marilyn L. Slovak, et al.. (2007). Aneusomy for detection of bladder cancer recurrence: a Southwest Oncology Group study. Cancer Genetics and Cytogenetics. 176(1). 22–27. 4 indexed citations
4.
Raju, Usha, et al.. (2006). Molecular Classification of Breast Carcinoma In Situ. Current Genomics. 7(8). 523–532. 15 indexed citations
5.
Wolman, Sandra R. & Stewart Sell. (1997). Human Cytogenetic Cancer Markers. Humana Press eBooks. 10 indexed citations
6.
Worsham, Maria J., Sandra R. Wolman, Thomas E. Carey, et al.. (1995). Common clonal origin of synchronous primary head and neck squamous cell carcinomas: Analysis by tumor karyotypes and fluorescence in situ hybridization. Human Pathology. 26(3). 251–261. 82 indexed citations
7.
Wolman, Sandra R., Anwar N. Mohamed, Gloria H. Heppner, & Herbert D. Soule. (1994). Chromosomal markers of immortalization in human breast epithelium. Genes Chromosomes and Cancer. 10(1). 59–65. 13 indexed citations
8.
Herrmann, Marille E., et al.. (1994). Chromosomal aberrations in two adrenocortical tumors, one with a rearrangement at 11p15. Cancer Genetics and Cytogenetics. 75(2). 111–116. 11 indexed citations
9.
Wolman, Sandra R.. (1992). The chromosomes in human cancer.. The American Journal of Human Genetics. 50(4). 880–881. 9 indexed citations
10.
Wolman, Sandra R., Robert J. Pauley, Anwar N. Mohamed, et al.. (1992). Genetic markers as prognostic indicators in breast cancer. Cancer. 70(S4). 1765–1774. 29 indexed citations
11.
Wolman, Sandra R., Helen Feiner, Roger Schinella, et al.. (1991). A retrospective analysis of breast cancer based on outcome differences. Human Pathology. 22(5). 475–480. 12 indexed citations
12.
Herrmann, Marille E., Gary B. Talpos, Anwar N. Mohamed, et al.. (1991). Genetic markers in thyroid tumors.. PubMed. 110(6). 941–7; discussion 947. 16 indexed citations
13.
Soule, Herbert D., Terry Maloney, Sandra R. Wolman, et al.. (1990). Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10.. PubMed. 50(18). 6075–86. 1258 indexed citations breakdown →
14.
Wolman, Sandra R. & A.S. Henderson. (1989). Chromosomal aberrations as markers of oncogene amplification. Human Pathology. 20(4). 308–315. 9 indexed citations
15.
Diamond, Leila & Sandra R. Wolman. (1989). Charlotte Friend, Ph.D. 1921‐1987 A Scientist's Life. Annals of the New York Academy of Sciences. 567(1). 1–13. 1 indexed citations
16.
Wolman, Sandra R., Patricia M. Camuto, & Mary Ann Perle. (1988). Cytogenetic diversity in primary human tumors. Journal of Cellular Biochemistry. 36(2). 147–156. 15 indexed citations
17.
Wolman, Sandra R., Lydia E. McMorrow, Isaiah J. Fidler, & James E. Talmadge. (1985). Development and progression of karyotypic variability in melanoma K1735 following X-irradiation.. PubMed. 45(4). 1839–44. 14 indexed citations
18.
Soper, Keith A., et al.. (1984). Sister-chromatid exchange (SCE) report on control subjects in a study of occupationally exposed workers. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 129(1). 77–88. 82 indexed citations
19.
Auerbach, Arleen D. & Sandra R. Wolman. (1976). Susceptibility of Fanconi's anaemia fibroblasts to chromosome damage by carcinogens. Nature. 261(5560). 494–496. 268 indexed citations
20.
Pochedly, Carl, et al.. (1971). Fanconi's anemia with growth hormone deficiency. The Journal of Pediatrics. 79(1). 93–96. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026